Unlock instant, AI-driven research and patent intelligence for your innovation.

Glycan composition for activating immunity to treat pathogen infection

A technology of composition and polysaccharide, which is applied in the direction of antibacterial, antifungal, antiviral, etc., and can solve the problems of inability to treat viral diseases, unstable effect, and reproductive barriers of breeding pigs.

Inactive Publication Date: 2015-07-22
黄永
View PDF1 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

2) Reproductive disorders of breeding pigs
4) Pork quality is reduced
However, due to the unstable effect of the application of a single component in practical applications, the effect of polysaccharides is not outstanding, and the use of human or animal after infection with viral diseases cannot achieve the effect of treating viral diseases.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Glycan composition for activating immunity to treat pathogen infection
  • Glycan composition for activating immunity to treat pathogen infection
  • Glycan composition for activating immunity to treat pathogen infection

Examples

Experimental program
Comparison scheme
Effect test

Embodiment approach 1

[0023] Add 10g of chitosan to 500ml of 0.5 mole hydrochloric acid, add 5g of octanoic acid, stir well at 35°C, add 15g of aluminum sulfate, 2g of calcium dextran, 20g of dipotassium hydrogen phosphate, and 10g of zinc threonine Stir well and evenly at 25°C. The pH value was adjusted to 2.9 with sulfuric acid to prepare a polysaccharide composition containing functional elements.

Embodiment approach 2

[0025] Using the classic in vitro anti-hepatitis B virus drug screening model HepG2.2.15 cell model, the composition of different concentrations was administered to HepG2.2.15 cells for several days, the cell supernatant was taken, and the hepatitis B surface antigen (HBsAg) and e antigen (HBeAg) were measured. And HBVDNA secretion to judge the drug effect. During the experiment, the cytotoxicity of the composition was determined by MTT method. The antiviral drug lamivudine (3TC), which has been proven effective in clinical application, was selected as the control.

[0026] When the HepG2.2.15 cells proliferate to a certain extent and the antigen secretion is stable, count the cells, take the cell suspension and culture it in a 96-well culture plate, 100 μL per well, so that the concentration of cells per well reaches 2000, after 24 hours of culture, aspirate The cell supernatant was added with different concentrations of the composition to continue culturing for 6 days, duri...

Embodiment approach 3

[0038] Select 30 pigs with symptoms of virus infection: progressive emaciation or growth retardation, anorexia, depression, slow movement, pale skin, disheveled coat, dyspnea, cough, etc. Divided into a treatment group and a control group, the age, clinical manifestations and disease severity of pigs in the two groups were basically the same. There are 15 cases in the treatment group and the control group. In the treatment group, 10ml of the composition is added to 500ml of drinking water, and each pig is supplied with 500ml / day. The control group was kept in isolation and managed routinely. After the treatment, the mental state, body temperature and feed intake of the pigs were observed every day. After 5 days of medication, the clinical symptoms of sick pigs disappeared, and those with normal body temperature, appetite, and mental state were judged as cured; after 5 days of medication, the sick pigs’ appetite and mental state improved, and those with normal body temperature...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a composition prepared by connecting glycan with functional elements through fatty acid or a salt or derivative of the fatty acid. The composition can enhance the immunity of human bodies and animals to substantially improve the pathogen infection treatment function of glycan, and especially has a substantial treatment effect on virus diseases. The composition is of positive significance to reducing the dependence of the breeding industry on antibiotics, and plays a great role in the development of antivirus preparations.

Description

technical field [0001] The invention relates to the application of a polysaccharide composition in the preparation of medicaments for activating immune resistance and treating human and animal diseases, and belongs to the field of biotechnology. Background technique [0002] The development of modern poultry and aquatic product breeding plays a very important role in my country's economic development and sustainable environmental development. However, with the improvement of breeding intensification, the density of poultry, fish, shrimp and crabs and other animals is high, coupled with the extensive use of hormones or antibiotics, the growth of animals is fast, the ability of animals to resist stress is significantly weakened, and immune resistance Low, it is very easy to cause the epidemic of diseases and cause a large number of animal deaths. [0003] In a stressful environment, the excitability of the feeding center of the animal body decreases, neuroendocrine disorders,...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/722A61K31/715A61P37/04A61P31/16A61P31/04A61P31/20A61P31/18A61P31/22A61P31/10A61P17/02
Inventor 黄永
Owner 黄永